Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 12OTHER 6NIH 3UNKNOWN 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 48Breast Neoplasms 48Lung Neoplasms 34Ovarian Neoplasms 33Fallopian Tube Neoplasms 22Carcinoma, Ovarian Epithelial 21Adenocarcinoma of Lung 16Unspecified Adult Solid Tumor, Protocol Specific 13Brenner Tumor 11Adenocarcinoma, Bronchiolo-Alveolar 11Head and Neck Neoplasms 10Breast Neoplasms, Male 10Neoplasm Metastasis 9Uterine Cervical Neoplasms 7Triple Negative Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Neoplasms 7Esophageal Neoplasms 7Endometrial Neoplasms 7Adenocarcinoma Of Esophagus 6Urinary Bladder Neoplasms 5Oropharyngeal Neoplasms 5Melanoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Peritoneal Neoplasms 4Mouth Neoplasms 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4

Interventions

Paclitaxel 3Cisplatin 2tofacitinib 1sodium thiosulfate 1sargramostim 1fludarabine 1aldesleukin 1Vaccines 1TKM-080301 1Surgical Procedures, Operative 1SS1(dsFv)PE38 1Positron Emission Tomography Computed Tomography 1Mitomycin 1Magnetic Resonance Imaging 1LMB-100 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fluorouracil 1Electrocardiography 1Cyclophosphamide 1Carboplatin 1Capecitabine 1Bevacizumab 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Adenocarcinoma × Paclitaxel × Clear all
NCT04034251 2026-05-05

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
12 enrolled 18 charts
GastrointestinalGynecologic

Adenocarcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT01051934 2017-07-02

A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
2 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00001569 2008-03-04

Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
74 enrolled
Gynecologic

Adenocarcinoma, Carcinoma, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡